Search

everythinglearnresearchcommunity

for

Search:↓

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Hair analysis can detect drug use but is costly and interpretation is complex.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Men need higher doses and tailored injection techniques for botulinum toxin treatments due to their unique facial features.

Oral minoxidil effectively controls blood pressure quickly and safely.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

PRP improves hair thickness for both genders, but only increases hair density in men.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

PRP, exosomes, and physical therapies show promise for hair and tissue repair, but need more research for optimization.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.